Table 2.
Pyruvate | state 2 | state 3 | state 4 | RCI |
---|---|---|---|---|
TC | 6.8 ±0.7 | 210.2 ±22.4 | 11.6 ±3.8 | 18.1 ±2.5 |
IR | 35.7 ±2.3§ | 112.0 ±33.9§ | 59.4 ±3.4§ | 2.2 ±2.0§ |
IR+PAX | 12.0 ±2.6*§ | 92.3 ±25.2§ | 53.4 ±3.6§ | 1.7 ±1.9§ |
IR+NS8593 | 30.9 ±2.1*§ | 145.1 ±37.0§ | 58.6 ±6.2§ | 2.3 ±3.0§ |
IR+PAX+NS8593 | 20.6 ±1.1*§ | 96.0 ±20.1§ | 59.4 ±3.7§ | 1.6 ±0.8§ |
Succinate | state 2 | state 3 | state 4 | RCI |
| ||||
TC | 64.5 ±0.8 | 450.4 ±37.5 | 79.5 ±10.3 | 5.7 ±0.5 |
IR | 72.0 ±3.2§ | 220.2 ±32.9§ | 129.0 ±12.0§ | 1.7 ±1.2§ |
IR+PAX | 90.1 ±6.1*§ | 286.2 ±38.8§ | 154.1 ±14.2§ | 1.8 ±1.1§ |
IR+NS8593 | 168.1 ±8.2*§ | 280.0 ±53.3§ | 161.1 ±18.2§ | 1.7 ±0.8§ |
IR+PAX+NS8593 | 116.1 ±9.5*§ | 246.0 ±38.5§ | 178.2 ±15.2*§ | 1.4 ±0.8§ |
Succinate+rotenone | state 2 | state 3 | state 4 | RCI |
| ||||
TC | 62.4 ± 9.8 | 290.5 ±56.2 | 76.8 ±0.8 | 3.8 ±0.6 |
IR | 87.2 ± 6.4 | 202.0 ±32.9 | 105.2 ±16.4§ | 1.9 ±0.7§ |
IR+PAX | 77.4 ±11.6 | 234.2 ±55.1 | 136.0 ±33.7§ | 1.7 ±0.8§ |
IR+NS8593 | 96.2 ±14.2§ | 312.0 ±48.6* | 261.3 ±38.2*§ | 1.2 ±0.8§ |
IR+PAX+NS8593 | 108.2 ±26.0§ | 305.3 ±45.7* | 262.3 ±31.6*§ | 1.2 ±0.7§ |
Respiration rate (O2 consumption, nmol/min/mg protein) was measured in cardiac mitochondria isolated at 20 min perfusion after 35 min global ischemia ± BKCa and SKCa channel antagonists NS8593 ± PAX given 20 min before and for 20 min after ischemia. RCI (respiratory control index) = state 3/state 4. Time controls (TC) were not subject to ischemia but 75 min perfusion. Note that the lower RCI’s after IR were not significantly lower after hearts were treated with PAX ± NS8593 compared to IR alone with any substrate. N = hearts/group with 3–4 replicates within each mitochondrial pellet. P<0.05;
IR + drugs vs. IR only;
IR ± drugs vs. TC.
See also Fig. 4A.